Mental Health

MIRA Pharmaceuticals Announces Ketamir-2 Outperforms Current FDA-Approved Neuropathic Pain Treatments, Gabapentin and Pregabalin, in Preclinical Study

MIAMI, FL / ACCESSWIRE / October 21, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a leading pre-clinical-stage pharmaceutical development company, is...

Curio Digital Therapeutics Applauded by Frost & Sullivan for Enhancing Women’s Maternal Mental Healthcare with its MamaLift and MamaLift Plus Solutions

MamaLift ensures personalized care tailored to each woman's journey through motherhood, empowering them to manage stress, embrace joy, and reduce...

WELL’s Subsidiary Wisp Launches Comprehensive Weight Care Vertical Inclusive of GLP-1 Medications to Support Women Struggling with Hormonal Imbalances

Wisp debuts its first-ever exclusive over-the-counter weight-loss supplement, designed to promote women's metabolic health.Wisp introduces personalized, online consultations with access...

New Study Shows Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Significantly Improves Memory and Cognitive Function in Alzheimer’s Patients

Groundbreaking Trial Reveals DIFS Increases Neural Activity and Blood Flow in the Hippocampus, Offering Hope for Alzheimer’s TreatmentHOUSTON, TX, Oct....

Psyence Biomed Provides Progress Update on PsyLabs E.U. Good Manufacturing Practices (GMP) Certified Active Pharmaceutical Ingredient (API) Development

PsyLabs to exclusively supply Psyence Biomed with high purity, pharmaceutical grade psilocybin for its second development indication, Alcohol Use Disorder,...

meQuilibrium Honors JPMorganChase, Dow Chemical, Liberty Mutual Insurance, Leidos, KBR, Charles River Labs, Point32 Health, and Qurate Retail Group for Achievements in Supporting Employee Resilience

error: Content is protected !!